FULL CIRCLES THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
FULL CIRCLES THERAPEUTICS, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 5 are pending. Notable registered marks include C4DNA and GATALYST. The owner is based in Cambridge, MA.
625 Mount Auburn St., Suite 105
Cambridge, MA 02138
Showing of trademarks Trademarks
Trademark Classifications
FULL CIRCLES THERAPEUTICS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does FULL CIRCLES THERAPEUTICS, INC. have?
FULL CIRCLES THERAPEUTICS, INC. has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 pending, 1 abandoned.
What trademark classes does FULL CIRCLES THERAPEUTICS, INC. file in?
FULL CIRCLES THERAPEUTICS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are FULL CIRCLES THERAPEUTICS, INC.'s most well-known trademarks?
FULL CIRCLES THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as C4DNA and GATALYST. These are among 2 currently registered trademarks in the portfolio.
What is FULL CIRCLES THERAPEUTICS, INC.'s trademark registration success rate?
FULL CIRCLES THERAPEUTICS, INC. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 5 applications are pending review.